Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE)
This study is ongoing, but not recruiting participants.
Study NCT00117572 Information provided by University of Chicago
First Received: June 30, 2005 Last Updated: September 23, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cancer of the Pharynx
Cancer of the Larynx
Cancer of the Nasal Cavity
Paranasal Sinus Neoplasms
Cancer of the Oral Cavity
Additional conditions recognized in this trial
Head and Neck Neoplasms
Laryngeal Neoplasms
Neoplasms
Pharyngeal Neoplasms
More general conditions related to this trial
Laryngeal Diseases
Neoplasms by Site
Nose Diseases
Nose Neoplasms
Otorhinolaryngologic Diseases
Otorhinolaryngologic Neoplasms
Paranasal Sinus Diseases
Pharyngeal Diseases
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Stomatognathic Diseases
Interventions listed in this trial
docetaxel
cisplatin
hydroxyurea
fluorouracil
chemotherapy
radiotherapy
More general drug interventions related to this trial
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antisickling Agents
Enzyme Inhibitors
Hematologic Agents
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Radiation-Sensitizing Agents
Therapeutic Uses
Sponsors listed in this trial
University of Chicago
Back to top of Main Content
